The soft agar assay also substantiated a similar outcome wherein the clone spots in the Bcl2-overexpressed HCT116 and sw620 cells treated with DET were smaller and fewer than those in the control group, but larger and more numerous in comparison to the colon cancer cells treated with DET (Figure 4F). This evidence concerns the gene BCL2 and colonic neoplasm.